Author(s)
Nogueira T1, Menezes P1, dos Santos F1, Abreu G1, Raimondi A2, Espinosa J2, Criniti J3, Di Boscio V4, Alfonso R5, Shen Q5, Beruto V6, Scibona P6, Savoy N6, Blugerman G6, Svetliza G6, Wainstein E6, Felice R2, Soares CS1
1GlaxoSmithKline, Rio de Janeiro, Brazil, 2GlaxoSmithKline plc., San Fernando, B, Argentina, 3GlaxoSmithKline plc., Victoria, Tigre, B, Argentina, 4GlaxoSmithKline plc., London, UK, 5GlaxoSmithKline plc, Collegeville, PA, USA, 6Hospital Italiano de Buenos Aires, Buenos Aires, B, Argentina
OBJECTIVES : Understanding about treatment of chronic obstructive pulmonary disease (COPD) patients in Argentina is limited. The objective is to describe the treatment profile of COPD patients affiliated to the Hospital Italiano (HI), in Buenos Aires, Argentina. METHODS : Retrospective cohort study using electronic medical records of COPD patients from 2014-2017. Patients with ≥40 years at index date with data available 1 year before (baseline) and after (follow-up) were identified. Index date was 1 year after the 1st diagnosis for incident cases and 01-Jan-2015 for prevalent cases (diagnosed before 01-Jan-2014). Treatment dispensed closest to the index date (prevalent) or used as initial treatment (incident) was evaluated, including controllers (inhaled corticosteroid [ICS], long-acting β2 agonist [LABA] or long-acting muscarinic antagonist [LAMA] and combinations), rescue medication and systemic corticosteroid (SC). RESULTS : We included 2,861 patients (24.3% incident and 75.7% prevalent). In incident patients, 43.6% had no medication dispensed during the study; 7.3% had SC only and 12.7% had rescue medication only. Initial maintenance therapy was ICS/LABA in 20.3% and triple in 1.2%. In prevalent patients, most (52.6%) had no dispensed medication during baseline. About 22% used ICS/LABA and 3.3% used triple closest to index date. In patients with previous severe COPD exacerbation (emergency room visits/hospitalisation), 18.3% had no dispensed medication and 10.1% used triple. CONCLUSIONS : There is a lack of optimised treatment in a high proportion of COPD patients affiliated to the HI, highlighting the need of additional care to COPD patients in Argentina.
Conference/Value in Health Info
2020-11, ISPOR Europe 2020, Milan, Italy
Value in Health, Volume 23, Issue S2 (December 2020)
Code
PRS57
Topic
Health Service Delivery & Process of Care
Topic Subcategory
Treatment Patterns and Guidelines
Disease
No Specific Disease